Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- CheckyesterdayChange DetectedThe webpage has updated its contact information for multiple principal investigators and added new recruiting dates, while removing outdated dates and a status of 'Suspended'.SummaryDifference0.8%
- Check8 days agoChange DetectedThe modernization of the ClinicalTrials.gov data ingest has been updated to July 2025, and several principal investigators and their contact information have been removed from the page.SummaryDifference4%
- Check16 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check23 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check30 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check37 days agoChange DetectedThe page has been updated to include new contact information for two principal investigators and their respective sites, while an earlier version of the page has been removed. Additionally, the revision number has been updated to reflect the latest changes.SummaryDifference0.8%
Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.